AB023
(17E,19E,21E,23E,25E)-4,6,10,12,14,16-hexahydroxy-3,15,27,28-tetramethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
Molecular Identity
AB023
(17E,19E,21E,23E,25E)-4,6,10,12,14,16-hexahydroxy-3,15,27,28-tetramethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
PubChem CID: 6474366
AB023 is a macrolide.
2D Structure
Properties
C31H50O8
Molecular Formula
550.70
Molecular Weight
g/mol
550.3506
Exact Mass
Da
4.4
XLogP
Drug-like (Lipinski: < 5)
148
TPSA
May have limited oral absorption
6
H-Bond Donors
8
H-Bond Acceptors
832
Complexity
SMILES
Canonical SMILES
SMILES: CC1C=CC=CC=CC=CC=CC(C(C(CC(CC(CCCC(CC(C(C(=O)OC1C)C)O)O)O)O)O)C)OIsomeric SMILES
SMILES: CC1/C=C/C=C/C=C/C=C/C=C/C(C(C(CC(CC(CCCC(CC(C(C(=O)OC1C)C)O)O)O)O)O)C)OSynonyms(13)
AB023xisomab 3G3RefChem:108462Anti-FXI Antibody Xisomab 3G3AB 023Anti-factor XI Monoclonal Antibody Xisomab 3G3AB023a(17E,19E,21E,23E,25E)-4,6,10,12,14,16-hexahydroxy-3,15,27,28-tetramethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one141443-39-2SCHEMBL29398072CHEBI:217192AKOS040747725Oxacyclooctacosa-17,19,21,23,25-pentaen-2-one, 4,6,10,12,14,16-hexahydroxy-3,15,27,28-tetramethyl-
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to AB023
Loading drug network...